Skip to main content
SpringerLink
Log in

Risk factors, etiology, and pathogenesis

  • Chapter
  • First Online:
Handbook of Lymphoma

Abstract

Lymphomas are a heterogeneous group of neoplastic disorders that originate from lymphatic cells. Clinical and epidemiological studies have revealed some risk factors that are associated with the development of lymphomas while molecular biology studies have elucidated mechanisms that drive the malignant transformation of lymphatic cells. In this chapter we review current knowledge of the risk factors and of the molecular pathogenesis of the most common lymphomas.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Beral V, Peterman T, Berkelman R, Jaffe H. AIDS-associated non-Hodgkin lymphoma. Lancet. 1991;337:805-809.

    Google Scholar 

  2. Levine AM. AIDS-related malignancies: the emerging epidemic. J Natl Cancer Inst. 1993;85:1382-1397.

    Google Scholar 

  3. Carbone A, Gloghini A. AIDS-related lymphomas: from pathogenesis to pathology. Br J Haematol. 2005;130:662-670.

    Google Scholar 

  4. Tajima K, Hinuma Y. Epidemiology of HTLV-I//II in Japan and the world. In: Takatsuki K, Hinuma Y, Yoshida M, eds. Advances in Adult T-cell Leukemia and HTLV-I Research (Gann Monograph on Cancer Research). Tokyo: Japan Scientific Societies Press; 1992. p. 129-149.

    Google Scholar 

  5. Tao Q, Robertson KD, Manns A, Hildesheim A, Ambinder RF. Epstein-Barr virus (EBV) in endemic Burkitt’s lymphoma: molecular analysis of primary tumor tissue. Blood. 1998;91:1373-1381.

    Google Scholar 

  6. Hamilton-Dutoit SJ, Raphael M, Audouin J, et al. In situ demonstration of Epstein-Barr virus small RNAs (EBER 1) in acquired immunodeficiency syndrome-related lymphomas: correlation with tumor morphology and primary site. Blood. 1993;82:619-624.

    Google Scholar 

  7. Camilleri-Broet S, Davi F, Feuillard J, et al. AIDS-related primary brain lymphomas: histopathologic and immunohistochemical study of 51 cases. The French Study Group for HIVAssociated Tumors. Hum Pathol. 1997;28:367-374.

    Google Scholar 

  8. Teruya-Feldstein J, Zauber P, Setsuda JE, et al. Expression of human herpesvirus-8 oncogene and cytokine homologues in an HIV-seronegative patient with multicentric Castleman’s disease and primary effusion lymphoma. Lab Invest. 1998;78:1637-1642.

    Google Scholar 

  9. Vannata B, Zucca E. Hepatitis C virus-associated B-cell non-Hodgkin lymphomas. Hematology Am Soc Hematol Educ Program. 2014;2014:590-598.

    Google Scholar 

  10. Zucca E, Bertoni F, Vannata B, Cavalli F. Emerging role of infectious etiologies in the pathogenesis of marginal zone B-cell lymphomas. Clin Cancer Res. 2014;20:5207-5216.

    Google Scholar 

  11. Jones Am, Gaspar HB. Immunogenetics: changing the face of immunodeficiency. J Clin Pathol. 2000;53:60-65.

    Google Scholar 

  12. Bakker NA, van Imhoff GW, Verschuuren EA, et al. Early onset post-transplant lymphoproliferative disease is associated with allograft localization. Clin Transplant. 2005;19:327-334.

    Google Scholar 

  13. Curtis RE, Travis LB, Rowlings PA, et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood. 1999;94:2208-2216.

    Google Scholar 

  14. Wolfe F, Michaud K. The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation. Arthritis Rheum. 2007;56:1433-1439.

    Google Scholar 

  15. Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:1937-1947.

    Google Scholar 

  16. Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103:275–282.

    Google Scholar 

  17. Johnson NA, Savage KJ, Ludkovski O, et al. Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival. Blood. 2009;114:2273-2279.

    Google Scholar 

  18. Savage KJ, Johnson NA, Ben- Neriah S, et al. MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy. Blood. 2009;114:3533-3537.

    Google Scholar 

  19. Belaud-Rotureau MA, Parrens M, Carrere N, et al. Interphase fluorescence in situ hybridization is more sensitive than BIOMED-2 polymerase chain reaction protocol in detecting IGH–BCL2 rearrangement in both fixed and frozen lymph node with follicular lymphoma. Hum Pathol.;38:365-372. 2007;38:365-372.

    Google Scholar 

  20. Pérez-Galán P, Dreyling M, Wiestner A. Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era. Blood. 2011;117:26-38.

    Google Scholar 

  21. Mozos A, Royo C, Hartmann E et al. SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. Haematologica. 2009;94:1555-1562.

    Google Scholar 

  22. Kwee I, Rancoita PM, Rinaldi A, et al. Genomic profiles of MALT lymphomas: variability across anatomic sites. Haematologica. 2001;96:1064-1066.

    Google Scholar 

  23. Klapproth K, Wirth T. Advances in the understanding of MYC- induced lymphomagenesis. Br J Haematol. 2010;149:484-497.

    Google Scholar 

  24. Swerdlow S, Campo E, Harris NL et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC 2008.

    Google Scholar 

  25. Marafioti T, Hummel M, Anagnostopoulos I, et al. Origin of nodular lymphocyte-predominant Hodgkin’s disease from a clonal expansion of highly mutated germinal-center B cells. N Engl J Med. 1997;337:453-458.

    Google Scholar 

  26. Hummel M, Ziemann K, Lammert H, Pileri S, Sabattini E, Stein H. Hodgkin’s disease with monoclonal and polyclonal populations of Reed-Sternberg cells. N Engl J Med. 1995;333: 901-906.

    Google Scholar 

  27. Thomas RK, Re D, Wolf J, Diehl V. Part I: Hodgkin’s lymphoma—molecular biology of Hodgkin and Reed–Sternberg cells. Lancet Oncol. 2004;5:11-18.

    Google Scholar 

  28. Kuppers R. The biology of Hodgkin’s lymphoma. Nat Rev Cancer. 2009;9:15-27.

    Google Scholar 

  29. Hinz M, Lemke P, Anagnostopoulos I, et al. Nuclear factor kappaB-dependent gene expression profiling of Hodgkin’s disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity. J Exp Med. 2002;196:605-617.

    Google Scholar 

  30. Skinnider BF, Elia AJ, Gascoyne RD, et al. Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood. 2002;99:618-626.

    Google Scholar 

  31. Ansell SM, Lesokhin AM, Borrello I, Halwani A, et al. PD-1 blockade with nivolumab in relapsed or refractory Hodgkin’s lymphoma. N Engl J Med. 2015;372:311-319.

    Google Scholar 

  32. Hummel M, Anagnostopoulos I, Dallenbach F, Korbjuhn P, Dimmler C, Stein H. EBV infection patterns in Hodgkin’s disease and normal lymphoid tissue: expression and cellular localization of EBV gene products. Br J Haematol. 1992;82:689-694.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland

    Anastasios Stathis

  2. Department of Medicine, Memorial Sloan, Kettering Cancer Center, New York, NY, USA

    Colette Owens

Authors
  1. Anastasios Stathis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Colette Owens
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Memorial Sloan Kettering Cancer Center, New York, New York, USA

    Anas Younes

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Stathis, A., Owens, C. (2016). Risk factors, etiology, and pathogenesis. In: Younes, A. (eds) Handbook of Lymphoma. Adis, Cham. https://doi.org/10.1007/978-3-319-08467-1_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-08467-1_2

  • Published:

  • Publisher Name: Adis, Cham

  • Print ISBN: 978-3-319-08466-4

  • Online ISBN: 978-3-319-08467-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation